HSV Based Virotherapy Market Analysis

The global Herpes simplex virus treatment market is segmented by type into anti-cancer oncolytic viruses, viral vectors gene therapy and viral immunotherapy, out of which, the anti-cancer oncolytic viruses segment is anticipated to hold the largest share in the market during the forecast period on account of growing investment in developing treatment methods for cancer backed by mounting cases of cancer. As per other report by the WHO, in 2020, Lung cancer was the cause of 1.80 million deaths, whereas 935 000 deaths were caused by colon and rectum cancer; liver cancer was responsible for 830 000 deaths of the total deaths and breast cancer caused 685000 deaths. Furthermore, increasing government funding to increases cancer screening, and curb the cases of cancer mortality, is estimated to boost the market growth. On the basis of end-user, the market is segmented into hospital, research center, specialty clinics, and others. Out of these, the research center segment is estimated to garner the major share over the forecast period owing to the ongoing clinical research on virotherapy with HSV.

Our in-depth analysis of the global market includes the following segments